Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
LEONARD E POST Insider Profile
4 Followers
LEONARD E POST, Director at uniQure, holds 0.00 shares in CG Oncology, Inc. (Ticker: CGON), holds 24.08K shares in uniQure (Ticker: QURE), holds 8.00K shares in Fulgent Genetics (Ticker: FLGT).
Profitable Transactions
2 out of 4 Profitable Transactions
Average Return
-35.00%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that LEONARD E POST holds in companies
Most Profitable Insider Trade
The most profitable trade made by LEONARD E POST
LEONARD E POST's Trading History
uniQure
Jun 21, 2024
Director
Uninformative Buy
―
$408.86K
Fulgent Genetics
Aug 03, 2022
Director
Uninformative Buy
―
$146.72K
CG Oncology, Inc.
Dec 17, 2024
Director
Uninformative Buy
600.00
$0.00
List of latest transactions for each holding click on a transaction to see LEONARD E POST's performance on stock
You May Also Like
LEONARD E POST insider profile FAQ
What is the percentage of profitable transactions made by LEONARD E POST?
The percentage of profitable transactions made by LEONARD E POST is 50%.
What is the average return per transaction made by LEONARD E POST?
The average return per transaction made by LEONARD E POST is -35.00%.
What stocks does LEONARD E POST hold?
LEONARD E POST holds: QURE, FLGT, CGON stocks.
What was LEONARD E POST’s latest transaction?
LEONARD E POST latest transaction was an Uninformative Buy of $600.00.
What was LEONARD E POST's most profitable transaction?
LEONARD E POST’s most profitable transaction was an Informative Sell of QURE stock on June 20, 2023. The return on the trade was 76.50%.
What is LEONARD E POST's role in uniQure?
LEONARD E POST's role in uniQure is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.